Pharmaceutical Products – Open-House-Rabattverträge 2026-06 - Safinamid. The Health Insurance Companies Pursue The Goal Of Concluding Discount Agreements With All Suitable Pharmaceutical Companies In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients, Combinations Of Active Ingredients Or Dosage Forms, Potencies Or Finished Medicinal Products Specified In The Respective Lot.
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
